摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 3-[4-(2,7-dimethyl-5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoate | 1392837-76-1

中文名称
——
中文别名
——
英文名称
methyl 3-[4-(2,7-dimethyl-5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoate
英文别名
methyl 3-[4-(2,8-dimethyl-11H-pyrrolo[2,1-c][1,4]benzodiazepin-6-yl)piperazin-1-yl]-2,2-dimethylpropanoate
methyl 3-[4-(2,7-dimethyl-5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoate化学式
CAS
1392837-76-1
化学式
C24H32N4O2
mdl
——
分子量
408.544
InChiKey
XREGPWZRUCHLBW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    30
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    50.1
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • SUBSTITUTED [(5H-PYRROLO[2,1-c][1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
    申请人:CAMP Anne Marie
    公开号:US20120202797A1
    公开(公告)日:2012-08-09
    A dual H1/5-HT 2A receptor antagonist of the formula: its uses, and methods for its preparation are described.
    一种双重H1/5-HT2A受体拮抗剂的公式、用途和制备方法被描述。
  • SUBSTITUTED PYRIDONES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP)
    申请人:WEINTRAUB Philip M.
    公开号:US20120202795A1
    公开(公告)日:2012-08-09
    The present invention relates to a series of 2,3,5-substituted pyridone derivatives of formula I: wherein R, R 1 , R 2 , R 3 and R 4 are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5′-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.
    本发明涉及一系列公式I的2,3,5-取代吡啶酮衍生物,其中R、R1、R2、R3和R4如本文所定义。本发明还涉及制备这些化合物的方法。本发明的化合物是聚(腺苷5'-二磷酸核糖)聚合酶(PARP)抑制剂,因此在医药领域中具有广泛的用途,特别是在治疗和/或预防多种疾病,包括与中枢神经系统和心血管疾病相关的疾病方面。
  • SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
    申请人:Eli Lilly and Company
    公开号:EP2683719B1
    公开(公告)日:2015-03-18
  • US8314092B2
    申请人:——
    公开号:US8314092B2
    公开(公告)日:2012-11-20
  • [EN] SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS<br/>[FR] COMPOSÉS D'ACIDE [(5H-PYRROLO[2,1-C] [1,4]BENZODIAZÉPIN-11-YL)PIPÉRAZIN-1-YL]-2,2-DIMÉTHYLPROPANOÏQUE SUBSTITUÉS UTILISÉS EN TANT QU'AGONISTES INVERSES DE H1/ANTAGONISTES DE 5-HT2A À DOUBLE ACTIVITÉ
    申请人:LILLY CO ELI
    公开号:WO2012109011A1
    公开(公告)日:2012-08-16
    A dual H1/5-HT2A receptor antagonist of the formula:, its uses, and methods for its preparation are described.
查看更多